Diabetic cardiomyopathy: does the type of diabetes matter?

ME Hölscher, C Bode, H Bugger - International journal of molecular …, 2016 - mdpi.com
In recent years, type 2 diabetes mellitus has evolved as a rapidly increasing epidemic that
parallels the increased prevalence of obesity and which markedly increases the risk of …

The diabetic cardiomyopathy: the contributing pathophysiological mechanisms

T Salvatore, PC Pafundi, R Galiero, G Albanese… - Frontiers in …, 2021 - frontiersin.org
Individuals with diabetes mellitus (DM) disclose a higher incidence and a poorer prognosis
of heart failure (HF) than non-diabetic people, even in the absence of other HF risk factors …

Diabetic cardiomyopathy-a comprehensive updated review

G Murtaza, HUH Virk, M Khalid, CJ Lavie… - Progress in …, 2019 - Elsevier
Diabetes causes cardiomyopathy and increases the risk of heart failure independent of
hypertension and coronary heart disease. This condition called “Diabetic Cardiomyopathy” …

Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?

M Mizamtsidi, SA Paschou, J Grapsa… - European journal of …, 2016 - Wiley Online Library
Background Although the increasing rate of cardiovascular mortality in patients with
diabetes is thought to be due to the coronary atherosclerosis caused mainly by …

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment

I Falcão-Pires, AF Leite-Moreira - Heart failure reviews, 2012 - Springer
Diabetes mellitus is an important and prevalent risk factor for congestive heart failure.
Diabetic cardiomyopathy has been defined as ventricular dysfunction that occurs in diabetic …

Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy

I Evangelista, R Nuti, T Picchioni, F Dotta… - International journal of …, 2019 - mdpi.com
The high incidence and poor prognosis of heart failure (HF) patients affected with diabetes
(DM) is in part related to a specific cardiac remodeling currently recognized as diabetic …

Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions

JL Huo, Q Feng, S Pan, WJ Fu, Z Liu, Z Liu - Cell death discovery, 2023 - nature.com
Diabetic cardiomyopathy (DCM) mainly refers to myocardial metabolic dysfunction caused
by high glucose, and hyperglycemia is an independent risk factor for cardiac function in the …

Contribution of impaired insulin signaling to the pathogenesis of diabetic cardiomyopathy

M Zamora, JA Villena - International journal of molecular sciences, 2019 - mdpi.com
Diabetic cardiomyopathy (DCM) has emerged as a relevant cause of heart failure among the
diabetic population. Defined as a cardiac dysfunction that develops in diabetic patients …

Concurrent diabetes and heart failure: interplay and novel therapeutic approaches

QG Karwi, KL Ho, S Pherwani, EB Ketema… - Cardiovascular …, 2022 - academic.oup.com
Diabetes mellitus increases the risk of developing heart failure, and the co-existence of both
diseases worsens cardiovascular outcomes, hospitalization, and the progression of heart …

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes

CH Mandavia, AR Aroor, VG DeMarco, JR Sowers - Life sciences, 2013 - Elsevier
Diabetes mellitus type 2 (T2DM) is a widespread chronic medical condition with prevalence
bordering on the verge of an epidemic. It is of great concern that cardiovascular disease is …